Post drug pricing controls shall be wholly reviewed

Published: 2002-08-05 06:57:00

Updated: 2002-08-05 06:57:00

By taking a chance for the public hearing at the National Assembly Health and Welfare Committee the pharmaceutical industry raised strong opinions that the current post drug pricing control policy should be entirely reviewed, viewing that the policy has reflected mainly the bottom prices by inspe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK